Почетна › Прекумерна телесна тежина › Илиноис

Клинички испитувања за Прекумерна телесна тежина во Илиноис

38 студии за Прекумерна телесна тежина бараат учесници на локации во Илиноис.

Градови во Илиноис

Официјален текст на студијата (англиски)

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Great Lakes Clinical Trials - West Wilson Avenue /ID# 282378, Chicago

Се регрутираФаза 2

Возраст од 18 до 75 · Сите полови · Ажурирано 2.10.2026 · NCT07752979

Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes

Charter Research LLC - Chicago, Chicago
Flourish Research - Chicago, Chicago
AMR Clinical - Chicago Oak Brook, Oak Brook

Се регрутираФаза 2

Возраст 18 и постари · Сите полови · Ажурирано 29.9.2026 · NCT07685808

Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss

Christie Clinic, Champaign

Се регрутираФаза 2

Возраст од 18 до 75 · Сите полови · Ажурирано 28.9.2026 · NCT07837973

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

Great Lakes Clinical Trials, Chicago
Clinical Investigation Spec Gurnee, Gurnee
Endeavor Health, Skokie
и уште 1

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 28.9.2026 · NCT07720271

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

Chicago Research Center, Inc, Chicago
Endeavor Health, Skokie

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 28.9.2026 · NCT07668414

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

Great Lakes Clinical Trials - Ravenswood, Chicago

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 28.9.2026 · NCT07794579

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

Cedar Crosse Research Center, Chicago
Northwestern University, Chicago
Endeavor Health - Family Medicine Administration, Evanston
и уште 1

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 28.9.2026 · NCT07595549

A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus

Research Site, Champaign
Research Site, Chicago

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 25.9.2026 · NCT07776509

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Rush University Medical Center, Chicago

Се регрутираФаза 3

Возраст од 18 до 70 · Сите полови · Ажурирано 24.9.2026 · NCT06937099

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

Ann and Robert Lurie Children's Hospital of Chicago, Chicago
University of Illinois at Chicago, Chicago

Се регрутираФаза 3

Возраст од 6 до 17 · Сите полови · Ажурирано 24.9.2026 · NCT06672549

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Rush University Medical Center, Chicago

Се регрутираФаза 3

Возраст од 18 до 70 · Сите полови · Ажурирано 24.9.2026 · NCT06937086

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

NorthShore University Health System, Skokie

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 22.9.2026 · NCT07282600

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

Great Lakes Clinical Trials - Ravenswood, Chicago

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 22.9.2026 · NCT07392190

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Research Site, Chicago
Research Site, Melrose Park

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 22.9.2026 · NCT07784270

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Endeavor Health-Northwest Community Healthcare, Arlington Heights
Eagle Clinical Research, Chicago
University of Chicago, Chicago
и уште 2

Се регрутираФаза 3

Возраст од 45 до 99 · Сите полови · Ажурирано 22.9.2026 · NCT07037433

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

Great Lakes Clinical Trials - Ravenswood, Chicago

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 22.9.2026 · NCT07353931

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

Great Lakes Clinical Trials - Ravenswood, Chicago

Се регрутираФаза 2

Возраст од 18 до 75 · Сите полови · Ажурирано 22.9.2026 · NCT07589608

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

AURORA-1 Clinical Site, Schaumburg

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 16.9.2026 · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

AURORA-2 Clinical Site, Schaumburg

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 16.9.2026 · NCT07743450

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

Elevate Clinical Research, Gurnee
Knownwell, Schaumburg
Endeavor Health, Skokie

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 14.9.2026 · NCT07351045

AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

University Of Chicago, Chicago

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 11.9.2026 · NCT07571005

AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

Chicago Research Center, Inc, Chicago

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 9.9.2026 · NCT07571109

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Great Lakes Clinical Trials - Ravenswood, Chicago

Се регрутираФаза 2

Возраст од 18 до 75 · Сите полови · Ажурирано 8.9.2026 · NCT06143956

A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight

Walgreens - Store 11760, Oak Park

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 4.9.2026 · NCT07745504

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

Kailera Clinical Site, Skokie

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 3.9.2026 · NCT07284901

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Flourish Research - Great Lakes Clinical Trials, Chicago
Endeavor Health, Skokie
Evanston Premier Healthcare Research LLC, Skokie

Се регрутираФаза 3

Возраст од 18 до 99 · Сите полови · Ажурирано 3.9.2026 · NCT07684235

Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

Kailera Clinical Site, Springfield

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 3.9.2026 · NCT07284875

BRIDGE & Friends Trial

University of Illinois Chicago, Chicago

Се регрутираДобредојдени се здрави волонтери

Возраст од 50 до 79 · Сите полови · Ажурирано 1.9.2026 · NCT07798557

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

Endeavor Health, Skokie

Се регрутираФаза 3

Возраст од 18 до 99 · Сите полови · Ажурирано 27.8.2026 · NCT07575399

Assess the Effects of Replacing Foods High in Refined Carbohydrates With Avocado on Biomarkers of Inflammation.

Illinois Institute of Technology, Chicago

Се регрутираДобредојдени се здрави волонтери

Возраст од 21 до 74 · Сите полови · Ажурирано 27.8.2026 · NCT07566325

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

Research Site, Champaign
Research Site, Chicago

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 25.8.2026 · NCT07784725

AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

Clinical Investigation Spec Gurnee, Gurnee
Evanston Premier Hlthcr Res, Skokie

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 17.8.2026 · NCT07509307

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

ACCOMPLISH-1 Research Site, Chicago

Се регрутираФаза 3

Возраст од 18 до 79 · Сите полови · Ажурирано 10.8.2026 · NCT07654361

Functional Improvement in OSA and COPD With a Telehealth LifeStyle and Exercise Intervention

Jesse Brown VA Medical Center, Chicago

Се регрутира

Возраст 18 и постари · Сите полови · Ажурирано 22.7.2026 · NCT06390345

FIM+DASH: Food is Medicine Intervention to Promote Healthy Eating and Blood Pressure Control

Mile Square Health Center Chicago, Chicago
Mile Square Health Center - Auburn Gresham, Chicago
Mile Square Health Center - Englewood, Chicago
и уште 1

Се регрутираФаза 2

Сите возрасти · Сите полови · Ажурирано 10.7.2026 · NCT07332741

Better Lifestyle Counseling for African American Women During Pregnancy

University of Illinois at Chicago, Chicago
University of Illinois at Chicago, Chicago

Се регрутира

Возраст од 18 до 40 · Жени · Ажурирано 9.7.2026 · NCT05234125

People With Multiple Sclerosis Treated With Ocrelizumab and GLP-1 Agonists

Northwestern Memorial Hospital, Chicago

Се регрутираНабљудувачка студија

Возраст од 18 до 70 · Сите полови · Ажурирано 17.3.2026 · NCT07207148

Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation

University of Chicago, Chicago

Се регрутираФаза 3

Возраст од 18 до 75 · Сите полови · Ажурирано 14.11.2025 · NCT06499857

Од ClinicalTrials.gov, податоци преземени 5.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.